Profile data is unavailable for this security.
About the company
Mabwell Shanghai Bioscience Co Ltd is a China-based company mainly engaged in the research, development, production and sales of innovative drugs and biosimilars. The Company's main products are antibodies, antibody drug conjugates (ADCs) drugs, recombinant proteins, small molecule chemical drugs and other drugs. The Company focuses on oncology and age-related diseases, such as immunology, ophthalmology, orthopedics and other fields. The Company conducts business in both domestic and overseas markets.
- Revenue in CNY (TTM)624.52m
- Net income in CNY-947.49m
- Incorporated2017
- Employees1.36k
- LocationMabwell Shanghai Bioscience Co Ltd4th Floor, Building 3No 576 (Chuangxiang Garden)Libing Rd, Pudong New AreaSHANGHAI 201210ChinaCHN
- Phone+86 2 158332260
- Fax+86 2 158585793
- Websitehttps://www.mabwell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.73bn | 1.36k | 56.81 | 6.65 | -- | 7.59 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 9.16bn | 2.27k | -- | 4.44 | -- | 8.49 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
| Bio-Thera Solutions Ltd | 845.32m | -368.84m | 10.05bn | 1.17k | -- | 20.75 | -- | 11.88 | -0.8908 | -0.8908 | 2.04 | 1.17 | 0.3702 | 0.7722 | 5.96 | -- | -16.15 | -16.38 | -33.76 | -22.22 | 74.99 | 77.05 | -43.63 | -62.11 | 0.4617 | -34.12 | 0.573 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| HitGen Inc | 498.51m | 114.11m | 12.12bn | 483.00 | 107.14 | 8.24 | -- | 24.31 | 0.2824 | 0.2824 | 1.24 | 3.67 | 0.2726 | 6.37 | 4.69 | 1,032,114.00 | 6.18 | 3.06 | 6.87 | 3.36 | 55.23 | 53.55 | 22.67 | 14.48 | 5.12 | 6.59 | 0.1674 | 34.32 | 14.99 | 10.08 | 26.13 | -15.65 | 3.16 | -- |
| InventisBio Co Ltd | 180.53m | -116.28m | 13.55bn | 185.00 | -- | 8.14 | -- | 75.06 | -0.2012 | -0.2012 | 0.3122 | 2.88 | 0.0988 | -- | 1.03 | 975,824.70 | -6.36 | -32.89 | -6.76 | -35.22 | 99.41 | -- | -64.41 | -682.73 | -- | -- | 0.0127 | -- | -9.02 | 25.00 | 15.41 | -- | -3.97 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 624.52m | -947.49m | 14.80bn | 1.36k | -- | 19.44 | -- | 23.69 | -2.37 | -2.37 | 1.56 | 1.90 | 0.1384 | 0.3458 | 14.57 | 441,048.00 | -21.06 | -29.90 | -36.19 | -36.18 | 88.72 | 85.56 | -152.14 | -1,188.68 | 0.8093 | -10.82 | 0.7353 | -- | 56.28 | 46.68 | 0.9031 | -- | 12.25 | -- |
| Sinocelltech Group Ltd | 1.89bn | -310.15m | 18.08bn | 2.28k | -- | -- | -- | 9.58 | -0.6964 | -0.6964 | 4.24 | -0.1083 | 0.5458 | 0.4325 | 3.04 | 828,989.10 | -8.37 | -22.66 | -29.60 | -48.25 | 93.51 | 95.52 | -15.33 | -42.96 | 0.5008 | -0.6753 | 1.02 | -- | 33.13 | 294.24 | 127.39 | -- | 23.95 | -- |
| BeBetter Med Inc | -100.00bn | -100.00bn | 19.60bn | 150.00 | -- | 91.01 | -- | -- | -- | -- | -- | 0.4785 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0116 | -- | -- | -- | 67.59 | -- | -- | -- |
Data as of Feb 11 2026. Currency figures normalised to Mabwell Shanghai Bioscience Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 5.86m | 2.91% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 4.12m | 2.05% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 3.59m | 1.78% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2025 | 3.17m | 1.57% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.52m | 1.25% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 2.46m | 1.22% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 2.29m | 1.14% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.02m | 1.00% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2025 | 1.99m | 0.99% |
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2025 | 1.77m | 0.88% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
